Singapore #2945 (v.4)
Base data
- Notified in
-
G/MA/QR/N/SGP/7 06/11/2024
- Version validity
-
01/09/2024 -
present
Current active version v.4
- Reporting member
- Singapore
- In force from
- End date
- In force
- General description
-
Non-automatic license for import and export of clinical research materials containing psychotropic substances
- National legal basis
-
Health Products Act; 2007 Health Products (Therapeutic Products as Clinical Research Materials) Regulations; 2016
- Administrative mechanism
-
More information can be found at: https://www.hsa.gov.sg/controlled-drugs-psychotropic-substances.
Administered by HSA. - Responsible entities
-
Health Sciences Authority
- HS version
-
HS 2022
- Referenced WTO document symbol
Meta data
- WTO justifications
-
XX:(b) - (b) necessary to protect human, animal or plant life or health;
GATT 1994 (GATT 1947 provisions)
Reported as: Article XX(b) of the GATT - Non-WTO commitments
-
UN Convention (1988) on Narcotic Drugs and Psychotropic Substances
Reported as: United Nations Convention on Psychotropic Substances, 1971 - Affected partners
- Non-affected partners
Measures
- Reported restrictions
- NAL , NAL-X
| Symbol |
|---|
|
NAL
|
|
NAL-X
|
Tariff lines
|
30
|
EX30
|
Clinical research materials which contain psychotropic substances as specified in the First Schedule...
|
|